The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).

[1]  N. Ali,et al.  gp63 in Stable Cationic Liposomes Confers Sustained Vaccine Immunity to Susceptible BALB/c Mice Infected with Leishmania donovani , 2008, Infection and Immunity.

[2]  N. Ali,et al.  Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response. , 2007, Vaccine.

[3]  A. Khamesipour,et al.  Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes. , 2007, Experimental parasitology.

[4]  A. Khamesipour,et al.  Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. , 2006, Vaccine.

[5]  A. Khamesipour,et al.  Leishmaniasis vaccine candidates for development: a global overview. , 2006, The Indian journal of medical research.

[6]  P. Andersen,et al.  Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses. , 2005, Biochimica et biophysica acta.

[7]  R. Coler,et al.  Second-generation vaccines against leishmaniasis. , 2005, Trends in parasitology.

[8]  K. Anam,et al.  INFLUENCE OF PHOSPHOLIPID COMPOSITION ON THE ADJUVANTICITY AND PROTECTIVE EFFICACY OF LIPOSOME-ENCAPSULATED LEISHMANIA DONOVANI ANTIGENS , 2005, The Journal of parasitology.

[9]  Thomas Rades,et al.  Lipid based particulate formulations for the delivery of antigen , 2005, Immunology and cell biology.

[10]  Y. Ikeda,et al.  Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. , 2005, Blood.

[11]  Y. Aramaki,et al.  Induction of antigen-dependent interleukin-12 production by negatively charged liposomes encapsulating antigens. , 2004, Vaccine.

[12]  O. Poulsen,et al.  Adjuvant effect of quaternary ammonium compounds in a murine model. , 2004, Toxicology letters.

[13]  Sven Frokjaer,et al.  Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. , 2004, Vaccine.

[14]  K. Anam,et al.  A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. , 2004, Vaccine.

[15]  P. Andersen,et al.  Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines , 2004, Infection and Immunity.

[16]  Manmohan J. Singh,et al.  Microparticles as vaccine adjuvants and delivery systems , 2003, Expert review of vaccines.

[17]  Hans P. Merkle,et al.  Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages , 2003, Pharmaceutical Research.

[18]  X. Jiao,et al.  Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization , 2003, Hepatology.

[19]  K. Anam,et al.  Characterization of Leishmania donovani Antigens Encapsulated in Liposomes That Induce Protective Immunity in BALB/c Mice , 2002, Infection and Immunity.

[20]  J. Bonnefoy,et al.  DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine. , 2002, Vaccine.

[21]  A. Khamesipour,et al.  Cytokine Gene Expression in Healing and Non‐Healing Cases of Cutaneous Leishmaniasis in Response to In vitro Stimulation with Recombinant gp63 Using Semi‐Quantitative RT–PCR , 2001, Scandinavian journal of immunology.

[22]  H. Merkle,et al.  Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[23]  R. Coler,et al.  Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease , 2001, Infection and Immunity.

[24]  B. Guy,et al.  Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine. , 2001, Vaccine.

[25]  K. Anam,et al.  INDUCTION OF PARTIAL PROTECTION AGAINST LEISHMANIA DONOVANI BY PROMASTIGOTE ANTIGENS IN NEGATIVELY CHARGED LIPOSOMES , 2000, The Journal of parasitology.

[26]  M. Wiese,et al.  Subunit Vaccination of Mice against New World Cutaneous Leishmaniasis: Comparison of Three Proteins Expressed in Amastigotes and Six Adjuvants , 2000, Infection and Immunity.

[27]  P. Andersen,et al.  ESAT-6 Subunit Vaccination againstMycobacterium tuberculosis , 2000, Infection and Immunity.

[28]  Koji Kariya-city Aichi-pref. Tanaka,et al.  Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[29]  F. Afrin,et al.  Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes , 1997, Infection and immunity.

[30]  R. Appelberg,et al.  Adjuvant modulation of immune responses to tuberculosis subunit vaccines , 1997, Infection and immunity.

[31]  W. McMaster,et al.  Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania 'major surface glycoprotein' (gp63). , 1995, Veterinary parasitology.

[32]  S. Reed,et al.  T-cell and cytokine responses in leishmaniasis. , 1993, Current opinion in immunology.

[33]  R. E. Pitas,et al.  Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. , 1992, Biochimica et biophysica acta.

[34]  E. Handman,et al.  Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice. , 1990, Experimental parasitology.

[35]  H. Arai,et al.  Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. , 1990, The Journal of biological chemistry.

[36]  R. Karess,et al.  The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage. , 1989, Molecular and biochemical parasitology.

[37]  D. Russell,et al.  The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. , 1986, Journal of immunology.

[38]  T. Boon,et al.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.

[39]  E. Javadian,et al.  Effectiveness of leishmanization in the control of cutaneous leishmaniasis. , 1983, Bulletin de la Societe de pathologie exotique et de ses filiales.

[40]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[41]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[42]  S Gordon,et al.  Macrophage receptors and immune recognition. , 2005, Annual review of immunology.

[43]  R. Locksley,et al.  The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.

[44]  Y. Aramaki,et al.  Interferon-γ inductive effect of liposomes as an immunoadjuvant , 1995 .

[45]  F. Galdiero,et al.  Beneficial effects of myristic, stearic or oleic acid as part of liposomes on experimental infection and antitumor effect in a murine model. , 1994, Life sciences.

[46]  H. Snippe,et al.  DDA as an immunological adjuvant. , 1992, Research in immunology.

[47]  W. McMaster,et al.  The major surface glycoprotein (GP63) is present in both life stages of Leishmania. , 1990, Molecular and biochemical parasitology.

[48]  C. Bordier.  The promastigote surface protease of Leishmania. , 1987, Parasitology today.